Debt (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
Jun. 26, 2025 |
Apr. 10, 2025 |
Nov. 08, 2024 |
Jul. 23, 2024 |
Sep. 08, 2023 |
Mar. 07, 2023 |
Dec. 19, 2022 |
Sep. 15, 2022 |
Apr. 04, 2022 |
Mar. 21, 2022 |
Nov. 20, 2021 |
Oct. 14, 2020 |
Jun. 09, 2020 |
Apr. 24, 2020 |
Apr. 23, 2020 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Sep. 30, 2023 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Sep. 30, 2025 |
Aug. 22, 2025 |
Apr. 08, 2025 |
Feb. 23, 2024 |
Dec. 11, 2023 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Dec. 15, 2021 |
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
263,062,097
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
$ 0.0154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 614,000
|
$ 577,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt covenant, cumulative net sales requirement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000,000.0
|
|
|
|
|
|
|
|
|
|
$ 100,000,000.0
|
|
|
|
|
| Debt instrument periodic payment |
|
|
|
|
|
$ 92,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cumulative net sales |
|
|
|
|
$ 100,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accrued interest percentage |
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest revenue expenses net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000.0
|
1,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,290,000)
|
1,603,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, debt default, description of notice of default |
|
|
the
Notices (the Third Amended Notice of Default) which added new claims of default based on (i) the Company’s failure to maintain
a cash position of $1.0 million or greater, as required under Section 5(b) of the Forbearance Agreement and (ii) the Company’s
failure to deliver financial and operating reports in accordance with the timeline required under the Section 8.1(n) of the Baker
Bros. Purchase Agreement, and claimed the outstanding balance under the notes of the Baker Stock Purchase Agreement, plus all
accrued and unpaid interest thereon, to be approximately $107.0 million as opposed to the Repurchase Price as defined in the Fourth
Amendment. The alleged Events of Defaults have not been waived or cured.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Coupon interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 600,000
|
600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Original principal and accrued interest amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,200,000
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
$ 0.0001
|
| Series G1 shares deemed dividends |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of debt |
$ 650
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
263,062,097
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
Aditxt April Notes’ and the Aditxt June Notes’ interest rates are subject to increase to 12% upon an event of default and
they have no Company right to prepayment prior to maturity; however, the Company has the option to redeem the respective notes at a redemption
premium of 32.5%. Aditxt can also require the Company to redeem the notes a) at the respective premium rate tied to the occurrence of
certain subsequent transactions, and b) in the event of subsequent placements (as defined in the respective SPAs). Also, pursuant to
the terms of the respective SPAs, Aditxt has certain rights to participate in subsequent issuances of the Company’s securities,
subject to certain exceptions, and the shares of Company Common Stock underlying the Aditxt April Offering and the Aditxt June Offering
are unregistered. Additionally, the conversion rate and warrant strike price are subject to adjustment upon the issuance of other securities
(as defined in the respective SPAs) below the stated conversion rate and strike price at issuance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 400,000
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series F-1 Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
| Share conversion price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0154
|
|
$ 0.0154
|
|
|
|
|
|
|
|
$ 0.0635
|
|
|
|
|
|
| Common Stock Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price |
|
$ 13,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Original principal and accrued interest amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreements [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Converted shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
608,787,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Security Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
$ 1,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,300,000
|
|
|
|
|
|
|
|
| Warrants to purchase |
92,407,592
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149,850,150
|
|
|
|
|
|
|
|
| Debt instrument interest rate effective percent |
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
$ 0.0154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offering costs |
$ 2,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Insurance Premium Finance Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Annual interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.82%
|
857.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 2022 Baker Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
|
|
582,886
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
|
|
|
|
|
|
|
|
$ 93.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Baker Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0154
|
|
|
|
|
|
|
|
|
|
| Senior Subordinated Notes [Member] | Security Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Interest Rate, Stated Percentage |
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
242,257,742
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Baker Bros Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt adjustment term |
|
|
|
|
|
|
|
2 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument conversion rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price, per share |
|
|
|
|
|
|
|
|
|
|
$ 4,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price as a percentage of lowest stock price |
|
|
|
|
|
|
|
|
|
|
115.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of sale of equity |
|
|
|
|
|
|
|
|
|
|
$ 50,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible notes payable |
|
|
|
$ 12,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 18,080,000
|
|
$ 20,097,000
|
|
|
|
|
$ 13,500,000
|
|
|
|
|
|
|
| Accumulated other comprehensive income |
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000.0
|
|
|
|
|
|
|
|
|
|
|
| Baker Bros Notes [Member] | Convertible Notes Payable [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt adjustment term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument interest rate effective percent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,000,000.0
|
$ 2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Written notice period |
|
|
|
|
|
|
|
|
|
|
|
|
|
10 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, benchmark price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,356.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price, per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Baker Bros Notes [Member] | Convertible Notes Payable [Member] | Debt Instrument, Redemption, Period Two [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, redemption price, percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Baker Bros Notes [Member] | Convertible Notes Payable [Member] | Debt Instrument, Redemption, Period One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, redemption price, percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
110.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Baker Bros Notes [Member] | Baker Second Closing Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase |
|
|
|
|
|
|
|
|
|
|
|
|
2,731
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Second Baker Amendment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price, per share |
|
|
|
|
|
|
|
|
|
$ 725.81
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt covenant, cumulative net sales requirement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000,000.0
|
|
|
|
|
| Conversion price percentage |
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
$ 20,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Second Baker Amendment [Member] | Baker Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 93.75
|
|
|
| Third Baker Amendment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price, per share |
|
|
|
|
|
|
|
$ 26.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Secured Creditor Forbearance Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument indebtedness amount |
|
|
|
|
|
|
$ 5,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short-term Convertible Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible notes payable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,200,000
|
|
15,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Principal and accrued interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 123,200,000
|
|
120,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Adjuvant Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument interest rate effective percent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price, per share |
|
|
|
|
|
|
|
|
$ 678.49
|
|
|
|
|
|
|
|
|
|
$ 0.0154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price as a percentage of lowest stock price |
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible notes payable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 33,384,000
|
|
32,770,000
|
|
|
|
|
|
|
|
|
|
|
|
| Converted shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,167,822,060
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Cash |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Adjuvant Notes [Member] | Short-term Convertible Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible notes payable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,400,000
|
|
$ 32,800,000
|
|
|
|
|
|
|
|
|
|
|
|
| Adjuvant Notes [Member] | Convertible Notes Payable [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
$ 25,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument conversion rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.50%
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price, per share |
|
|
|
|
|
|
|
$ 26.25
|
|
|
|
$ 6,843.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt covenant, cumulative net sales requirement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000,000.0
|
|
|
$ 100,000,000.0
|
|
| Debt instrument weighted average price per share |
|
|
|
|
|
|
|
|
$ 18,750
|
|
|
$ 18,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument weighted average period |
|
|
|
|
|
|
|
|
30 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument convertible exchange percentage |
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Amount |
|
|
|
|
|
|
|
$ 2,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Converted shares |
|
|
|
|
|
|
|
109,842
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible debt current principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,500,000
|
|
$ 22,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible debt current accrued interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,900,000
|
|
$ 10,300,000
|
|
|
|
|
|
|
|
|
|
|
|
| Adjuvant Notes [Member] | Convertible Notes Payable [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument convertible beneficial ownership limitation |
|
|
|
|
|
|
|
|
|
|
|
19.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| A80 Senior Subordinated Notes Due 2025 Issued December2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Redemption premium percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.50%
|
|
|
|
| A80 Senior Subordinated Notes Due 2025 Issued December2022 [Member] | Unsecured Debt [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Interest Rate, Stated Percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
|
| Interest rate increase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.00%
|
|
|
|
| Aditxt Note [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Converted shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
260,190,463
|
|
|
|
|
|
|
|
|
|
|
|
|
|